Haemopoietic stem cell transplantation is a curative treatment option with minimal transplant-related complications for patients with severe Glanzmann's thrombasthenia

Abstract

Glanzmann's thrombasthenia is a rare autosomal recessive bleeding disorder of platelet function caused by a qualitative or quantitative defect of the platelet membrane glycoprotein IIb/IIIa. For patients with a severe form the condition haemopoietic stem cell transplantation (HSCT) is the only